Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose conversion model between follitropin alfa and follitropin delta in Japanese women undergoing ART
jRCT1031260453Active, not recruiting
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of follitropin alfa and follitropin delta, sponsored by none. Started Sep 2026; status: active, not recruiting.
02
Drugs
follitropin alfafollitropin delta
Beyond the preview
Go deeper on jRCT1031260453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260453.